Literature DB >> 8464808

The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.

H Jeffery1, S S Davis, D T O'Hagan.   

Abstract

Poly(lactide-co-glycolide) (PLG) microparticles with entrapped antigens have recently been investigated as controlled-release vaccines. This paper describes the preparation of PLG microparticles with an entrapped model antigen, ovalbumin (OVA), using a (water-in-oil)-in-water emulsion solvent evaporation technique. In a series of experiments, the effects of process parameters on particle size and OVA entrapment were investigated. It was found that smooth, spherical microparticles 1-2 microns in diameter containing up to 10% (w/w) OVA could be produced using a small volume of external aqueous phase containing a high concentration of emulsion stabilizer and a 1:5 antigen:polymer ratio. PAGE analysis, isoelectric focusing, and Western blotting of OVA released from the microparticles in vitro confirmed that the molecular weight and antigenicity of the protein remained largely unaltered by the entrapment procedure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464808     DOI: 10.1023/a:1018980020506

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Biodegradable microparticles as controlled release antigen delivery systems.

Authors:  D T O'Hagan; D Rahman; J P McGee; H Jeffery; M C Davies; P Williams; S S Davis; S J Challacombe
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

Authors:  S J Challacombe; D Rahman; H Jeffery; S S Davis; D T O'Hagan
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

3.  Controlled release microparticles for vaccine development.

Authors:  D T O'Hagan; H Jeffery; M J Roberts; J P McGee; S S Davis
Journal:  Vaccine       Date:  1991-10       Impact factor: 3.641

4.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

5.  The uptake and translocation of latex nanospheres and microspheres after oral administration to rats.

Authors:  P Jani; G W Halbert; J Langridge; A T Florence
Journal:  J Pharm Pharmacol       Date:  1989-12       Impact factor: 3.765

6.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.

Authors:  Y Ogawa; M Yamamoto; H Okada; T Yashiki; T Shimamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-03       Impact factor: 1.645

7.  Vaccines for the Third World.

Authors:  B R Bloom
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

8.  Release of human serum albumin from poly(lactide-co-glycolide) microspheres.

Authors:  M S Hora; R K Rana; J H Nunberg; T R Tice; R M Gilley; M E Hudson
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

9.  The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method.

Authors:  R Bodmeier; J W McGinity
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

10.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.

Authors:  Y Tabata; Y Ikada
Journal:  Biomaterials       Date:  1988-07       Impact factor: 12.479

View more
  42 in total

1.  Bacterial inactivation by using near- and supercritical carbon dioxide.

Authors:  A K Dillow; F Dehghani; J S Hrkach; N R Foster; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.

Authors:  B Baras; M A Benoit; L Dupré; O Poulain-Godefroy; A M Schacht; A Capron; J Gillard; G Riveau
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Microsphere preparation using the untoxic solvent glycofurol.

Authors:  Daniela Allhenn; Alf Lamprecht
Journal:  Pharm Res       Date:  2010-10-29       Impact factor: 4.200

4.  Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

Authors:  K J Maloy; A M Donachie; D T O'Hagan; A M Mowat
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

5.  Influence of shaking and surfactants on the release of bsa from plga microspheres.

Authors:  R M Hernádez; M Igartua; A R Gascón; M B Calvo; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

6.  Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  K Allaoui-Attarki; S Pecquet; E Fattal; S Trollé; E Chachaty; P Couvreur; A Andremont
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Targeting to intestinal M cells.

Authors:  M A Jepson; M A Clark; N Foster; C M Mason; M K Bennett; N L Simmons; B H Hirst
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

8.  5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.

Authors:  Yuting Lin; Yan Li; Chui Ping Ooi
Journal:  J Mater Sci Mater Med       Date:  2012-07-29       Impact factor: 3.896

9.  Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method.

Authors:  Bi-Botti C Youan; Alamdar Hussain; Nga T Nguyen
Journal:  AAPS PharmSci       Date:  2003

10.  Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles.

Authors:  Tsukasa Matsumoto; Masaaki Noguchi; Osamu Hayashi; Kimiko Makino; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.